Tvardi Therapeutics Inc.

NASDAQ: TVRD · Real-Time Price · USD
24.30
0.51 (2.14%)
At close: Aug 15, 2025, 3:59 PM
24.00
-1.23%
After-hours: Aug 15, 2025, 04:10 PM EDT

Tvardi Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-70.87M -17.35M -20.54M -88.44M
Depreciation & Amortization
192K 95K 85K 1.55M
Stock-Based Compensation
n/a 314K 246K n/a
Other Working Capital
5.36M -3.96M 2.67M 7.96M
Other Non-Cash Items
24.86M -143K -321K 21.54M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-15.1M -3.96M 2.67M 5.26M
Operating Cash Flow
-60.92M -21.04M -17.87M -60.09M
Capital Expenditures
-1.05M n/a -50K -39K
Cash Acquisitions
n/a n/a n/a 70K
Purchase of Investments
-32.21M n/a -43.99M -208.79M
Sales Maturities Of Investments
82M 22.47M 22.05M 204.01M
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
48.74M 22.47M -22M -4.75M
Debt Repayment
-3.6M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
-3.6M 2K 4K 46.61M
Net Cash Flow
-14.28M 1.43M -39.86M -18.23M
Free Cash Flow
-61.96M -21.04M -17.92M -60.13M